Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.35−0.79 (-7.75%)
Close on Nov 13, 2026Market cap $278.37MP/E –Yield –
Turn Therapeutics cash
Cash and short-term investments held at the end of each period.
Turn Therapeutics's cash was $9.43M at Sep 30, 2026. For fiscal 2025 it was $4.03M, up 361.6% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.03M | +361.6% |
| FY2024 | Dec 31, 2024 | $872.60K | -26.1% |
| FY2023 | Dec 31, 2023 | $1.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $9.43M | +203.7% |
| Q2 FY2026 | Jun 30, 2026 | $9.95M | +211.9% |
| Q1 FY2026 | Mar 31, 2026 | $11.01M | +600.1% |
| Q4 FY2025 | Dec 31, 2025 | $4.03M | +361.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.11M | +523.4% |
| Q2 FY2025 | Jun 30, 2025 | $3.19M | +170.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.57M | – |
| Q4 FY2024 | Dec 31, 2024 | $872.60K | – |
| Q3 FY2024 | Sep 30, 2024 | $498.29K | – |
| Q4 FY2023 | Dec 31, 2023 | $1.18M | – |
See a number that looks wrong?